YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of … – Yahoo Finance

Posted on December 20, 2010 by admin

Results presented at the 52nd American Society of Hematology Annual Meeting “Anemia is the most serious symptom associated with myelofibrosis, so I am highly encouraged by the emerging activity profile of CYT387, which uniquely continues to demonstrate a … Bing News – Full Story →

Share

Related posts:

  1. Cyclacel Reports Phase 2 Survival Data With Sapacitabine in Myelodysplastic Syndromes at 2010 ASH … – Yahoo Finance
  2. Promising Data on Amgen Drug – Yahoo Finance
  3. XenoPort Reports Third Quarter Financial Results – Yahoo Finance
  4. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohn’s Disease to be … – Yahoo Finance
  5. Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets – Yahoo Finance
This entry was posted in Anemia and tagged , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>